Abstract
Many new drug candidates being developed within the pharmaceutical industry possess immunological activity, which may eventually necessitate an evaluation of potential toxicity to the immune system. At present, no consensus exists on which immunotoxicological procedures are most suitable for incorporation into the routine toxicology studies. This paper describes a few immunological test procedures that seem feasible for extrapolating to man, since similar approaches are now used clinically to evaluate immune reactivity. At present, data demonstrating the efficacy of immunotoxicological assays have been limited to humans exposed to environmental contaminants.
